Jesus Soberino
- 4.4 Good • 6 reviews
- 18 years of experience
- accreditation:
- Spain, Barcelona, Hospital Quiron Barcelona
Dr. Soberino has contributed to pivotal trials that revolutionized melanoma treatment with drugs like Pembrolizumab and Nivolumab.
- Specializes in immunotherapy for melanoma at Hospital Quiron Barcelona
- Key participant in trials leading to FDA-approved drugs
- Member of Vall d’Hebron’s Melanoma Unit, a leading oncology center
- Focuses on overcoming hormone therapy resistance in breast cancer
- Read more